HCA Healthcare, Inc. (HCA) AI Stock Summary

Snapshot

HCA Healthcare is a large, profitable hospital operator generating significant cash. Revenue grew to $75.6 billion in FY 2025, producing $6.78 billion in net income and $7.69 billion in free cash flow. The balance sheet carries substantial debt at $50.2 billion against only $1.04 billion in cash, though the cash flow is large enough to service it. The company has been aggressively returning capital to shareholders, reducing the share count by 11.9% over the last year. However, recent performance shows pressure from a shift toward more uninsured patients, prompting a cut to the full-year outlook.

What's Happening Right Now

• Tue 14th Jul '26 · Guidance Cut: HCA pre-announced Q2 2026 revenue of $20.23 billion but cut its full-year 2026 guidance, citing an unfavorable shift in payer mix toward uninsured patients and declining surgical volumes.
• Wed 27th May '26 · Acquisition: HCA agreed to acquire The College of Health Care Professions to strengthen its talent pipeline and workforce development ecosystem.
• Mon 27th Apr '26 · Debt Offering: The company announced a proposed public offering of senior notes, with proceeds intended for general corporate purposes or repayment of outstanding borrowing.

Bottom Line

HCA is a financially healthy business that is currently facing a challenging environment with more uninsured patients and lower surgical volumes. The company generates strong cash flow and buys back its own stock, but the recent guidance cut reflects real pressure on margins. With the stock trading near its 52-week low, investors are deciding whether this is a temporary dip or a sign of longer-term structural issues in healthcare payments.